Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.604NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.111NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.619NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.36.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.36.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.23.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.316NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.436NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.558NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.518NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.368NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.404NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.306NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.328NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.533NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KC.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KL.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HC.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-4273.88South Korea
B.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.507NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.54NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.196NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-3484.59South Korea
B.1.1.57NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.34NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.459NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.117NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.381NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.237NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.382NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.395NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.37NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.61NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.153NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.62NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.391NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.448NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.1 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.46 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.99 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.322NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.416NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.239NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used